To further prove this concept, we treated Rip1-Tag2 mice and colorectal cancer-bearing mice with P-sel-Fc and found that P-sel-Fc significantly inhibited tumor growth by abolishing platelets aggregation (Figure 3). Here, SELP is linked to colorectal cancer.